This position paper presents facts and figures regarding the evolution of interactions between pharma companies and physicians, and makes practical recommendations to ensure regular and impactful interactions in the years to come
News
In this 3rd position paper of its 2023 Medical Series, Smart Pharma Consulting analyses strategic, tactical and organizational best practices of...
This 2nd position paper of our 2023 Medical Series proposes 5 recommendations and several tools to develop High-Performance...
In this position paper – the first of our 2023 Medical Series – we provide insights and...